Clinical Trials Update: April 16, 2009

Ocular Hypertension Diabetes Mellitus, Type 2 Chronic Obstructive Pulmonary Disease (COPD) Gout Malaria Vaccine Female Sexual Dysfunction

(HealthDay News) -- Here are the latest clinical trials, courtesy of CenterWatch and ClinicalConnection.com:

Ocular Hypertension

If you are at least 21 and have been diagnosed with open-angle glaucoma or ocular hypertension in at least one eye and are currently being treated with Istalol or Betimol, you may qualify for this study.

The research site is in Philadelphia, Penn.

More information

Please see http://www.centerwatch.com/clinical-trials/listings/studylist.aspx?CatID=202.

-----

Diabetes Mellitus, Type 2

If you are an adult with type 2 diabetes and have trouble controlling your blood sugar with your current treatment regimen, you may qualify for this study.

The research site is in Midvale, Utah.

More information

Please see http://www.centerwatch.com/clinical-trials/listings/studylist.aspx?CatID=603.

-----

Chronic Obstructive Pulmonary Disease (COPD)

If you are a smoker or ex-smoker aged 40 or older with a diagnosis of moderate-to-severe chronic obstructive pulmonary disease (COPD), you may qualify for this study.

The research site is in Minneapolis, Minn.

More information

Please see http://www.centerwatch.com/clinical-trials/listings/studylist.aspx?CatID=44.

-----

Gout

If you have gout, you may be eligible for this study. It is evaluating an investigational medicine to prevent acute gout flares, when used in combination with an FDA-approved gout medication.

The research site is in Gilbert, Ariz.

More information

Please see http://www.clinicalconnection.com/clinical_trials/condition/gout.aspx.

-----

Malaria Vaccine

To participate in this study of a malaria vaccine, you must be aged 18 to 50, in good health, and have never had malaria.

The research site is in Silver Spring, Md.

More information

Please see http://www.clinicalconnection.com/clinical_trials/condition/malaria.aspx.

-----

Female Sexual Dysfunction

If you are concerned about female sexual dysfunction, you may qualify for this study. Participants will receive all study related care and an investigational medication at no cost, and may be compensated for time and travel.

The research site is in Chicago, Ill.

More information

Please see http://www.clinicalconnection.com/clinical_trials/condition/sexual_dysfunction.aspx.

-----

Copyright 2009 CenterWatch and ClinicalConnection.com. All rights reserved.

Consumer News